1-5 of 5
Yong Wu
Close
Sort by
Journal Articles

Study on the TGF-β Ligand Trap Enhances Erythroid Differentiation in HEL Cell By Inhibiting Smad3 Phosphorylation

Lanyue Hu, Nainong Li, Yong Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6354.
https://doi.org/10.1182/blood-2023-181693
Published: 2023
Journal Articles

Metformin Potentiates Gilteritinib Sensitivity Via Targeting PLK1 Signaling: A Strategy to Improve Outcomes and Reduce Costs in Treating FLT3-Mutated Acute Myeloid Leukemia

Meiling Chen, Chao Shen, Yi Chen, Keren Zhou, Wei Li, Zhenhua Chen, Chengwu Zeng, Ying Qing, Dong Wu, Kitty Wang, Xiaolan Deng, Jianda Hu, Yong Wu, Jianjun Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 1427.
https://doi.org/10.1182/blood-2023-187751
Published: 2023
Journal Articles

Dual Inhibition of Bcr-Abl and Hsp90 By C086 Potently Inhibits the Proliferation of Imatinib-Resistant CML Cells

Lixian Wu, PhD, Jing Yu, Yang Liu, PhD, Lou Liguang, Yong Wu, PhDMD, Yuanzhong Chen, MD, Jianhua Xu, PhD
Journal: Blood
Blood (2014) 124 (21): 914.
https://doi.org/10.1182/blood.V124.21.914.914
Published: 2014
Journal Articles

A Novel Subtype-Classifier Of Pediatric Acute Lymphoblastic Leukemia Using Gexp Multiplexed System

Han Zhang, MD. PhD, Xianping Zeng, Yanfen Chen, Qingqing Wang, Hao Cheng, Xiaoxi Zhao, Chao Gao, Jin Yan, Yong Wu, PhD, Jingdong Han, PhD, Huyong Zheng, MD. PhD
Journal: Blood
Blood (2013) 122 (21): 2589.
https://doi.org/10.1182/blood.V122.21.2589.2589
Published: 2013
Journal Articles

CKS1B Mediates SKP2/p27Kip1-Independent Myeloma Cell Survival and Disease Progression through Activation of MEK/ERK and JAK/STAT3 Signaling Pathways.

Fenghuang Zhan, MD, PhD, Lei Shi, MD, Siqing Wang, MD, MS, Hongwei Xu, MD, Thai M. Cao, MD, Chunjiao Xu, MD, PhD, Yong Wu, MD, PhD, Maurizio Zangari, MD, Guiyuan Li, MD, PhD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 126.
https://doi.org/10.1182/blood.V114.22.126.126
Published: 2009